Log in

NTHI NeOnc Technologies Holdings, Inc. NASDAQ · United States

NeOnc Technologies Holdings (NTHI) news NTHI going concern, IPO and offering news

Latest NeOnc Technologies Holdings news

  1. Mergers

    NeOnc Technologies signs up to $50 million investment deal with Quazar at $25 per share

    Quazar Investment would buy 1.4 million shares and fund trials and infrastructure in the UAE and MENA region. Closing still depends on a capital formation round.

  2. Financings

    NeOnc Technologies sets Nasdaq direct listing, registers 2,101,313 shares for resale

    NeOnc's prospectus registers 2,101,313 shares for resale in a Nasdaq direct listing, and the company gets none of the proceeds. Its financial advisor RBW Capital Partners is also the placement agent for a $10 million private placement, and the auditor's report carries a going concern paragraph.

NeOnc Technologies Holdings annual financials

LineFY2025FY2024
Revenue$39,990$83,000
Research and development$3.6 million$3.0 million
Net income (loss)-$62.1 million-$11.9 million
Cash from operations-$20.4 million-$4.2 million
Cash and equivalents$58,729$64,893

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $2.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about NeOnc Technologies Holdings

Has NeOnc Technologies Holdings issued a going-concern warning?

Our latest story on this, dated Mar 25, 2025: "NeOnc Technologies sets Nasdaq direct listing, registers 2,101,313 shares for resale". The story links the filing or release it is based on. Read the story.

When did NeOnc Technologies Holdings go public?

Our latest story on this, dated Mar 25, 2025: "NeOnc Technologies sets Nasdaq direct listing, registers 2,101,313 shares for resale". The story links the filing or release it is based on. Read the story.

Has NeOnc Technologies Holdings raised money recently?

Our latest story on this, dated Mar 25, 2025: "NeOnc Technologies sets Nasdaq direct listing, registers 2,101,313 shares for resale". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of NeOnc Technologies Holdings?

NeOnc Technologies Holdings, Inc. trades under the ticker NTHI on NASDAQ.

Where is NeOnc Technologies Holdings listed?

NeOnc Technologies Holdings, Inc. is listed on NASDAQ.

What is the SEC CIK of NeOnc Technologies Holdings?

The SEC Central Index Key (CIK) for NeOnc Technologies Holdings, Inc. is 1979414. Its filings are on SEC EDGAR.

How many shares does NeOnc Technologies Holdings have outstanding?

25,936,365 shares as of 2026-08-10, per the cover page of its 10-Q filed 2026-08-10.

Which country or territory is NeOnc Technologies Holdings listed under?

Our directory records NeOnc Technologies Holdings, Inc. under United States.

What does NeOnc Technologies Holdings do?

Our directory classifies NeOnc Technologies Holdings, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of NeOnc Technologies Holdings?

The ISIN recorded for NeOnc Technologies Holdings, Inc. is US64051A1016.

Does aibio.space cover NeOnc Technologies Holdings?

aibio.space lists NeOnc Technologies Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is NeOnc Technologies Holdings incorporated?

SEC records list its state or country of incorporation as DE.

What was NeOnc Technologies Holdings's revenue last year?

$39,990 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is NeOnc Technologies Holdings profitable?

NeOnc Technologies Holdings, Inc. reported a net loss of $62.1 million for the fiscal year ended Dec 31, 2025, and used $20.4 million of cash in operations, per its annual report to the SEC.

How much does NeOnc Technologies Holdings spend on research and development?

$3.6 million in the fiscal year ended Dec 31, 2025, per its annual report.

Investor discussion: NeOnc Technologies Holdings

Members talk about NeOnc Technologies Holdings (NTHI). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at NeOnc Technologies Holdings, newest first. Each line links the filing it comes from.

  1. Financings

    Reported a financing. SEC Form 8-K (Items 3.03,5.03,7.01,9.01). Source

  2. Financings

    Reported a financing. SEC Form 424B5. Source

  3. Financings

    Reported a financing. SEC Form 8-K (Items 1.01,3.02,3.03,5.03,9.01). Source

  4. Financings

    Reported a financing. SEC Form 424B5. Source

  5. Financings

    Reported a financing. SEC Form 8-K (Items 1.01,3.02,7.01,9.01). Source

  6. Financings

    Filed a final prospectus for a securities offering. SEC Form 424B4. Source

  7. Legal

    Said earlier financial statements should no longer be relied on. SEC Form 8-K (Items 4.02). Source

  8. Distress

    Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source

  9. Mergers

    Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,7.01,9.01). Source

  10. Financings

    Reported an unregistered sale of its securities. SEC Form 8-K (Items 1.01,2.03,3.02,9.01). Source

  11. Financings

    Filed a final prospectus for a securities offering. SEC Form 424B5. Source

  12. Distress

    Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. Source

  13. Legal

    Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source

  14. Financings

    Reported a financing. SEC Form 424B4. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:NTHI on TradingView.

SEC filings and registration

SEC name
Neonc Technologies Holdings, Inc.
CIK
1979414
Industry (SIC)
Pharmaceutical Preparations (2834)
US tickers
NTHI (Nasdaq)
State or country of incorporation
DE
Fiscal year ends
December 31
Filer category
<br>Emerging growth company
Business address
23975 PARK SORRENTO, CALABASAS, CA, 91302
Phone
310 663 7831
Shares outstanding
25,936,365 as of 2026-08-10 (10-Q filed 2026-08-10)

Recent filings (8-K and 6-K are the company's own announcements)

  • 8-K filed 2026-10-22
  • 8-K filed 2026-10-15
  • 8-K filed 2026-09-28
  • 8-K filed 2026-09-21
  • 8-K filed 2026-09-17
  • 8-K filed 2026-09-10
  • 424B5 filed 2026-09-10
  • 8-K filed 2026-08-20

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

NeOnc Technologies Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NTHI, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
NeOnc Technologies Holdings, Inc.
Ticker
NTHI
Listing
NASDAQ
Country or territory
United States
Business scope
Biotechnology
ISIN
US64051A1016
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.